DUALITYBIO-B plans to issue RMB shares for listing on the Shanghai Stock Exchange's Sci-Tech Innovation Board
DUALITYBIO-B plans to issue RMB shares on October 17, 2025, and list on the Shanghai Stock Exchange's Sci-Tech Innovation Board. The issuance will be subject to market conditions, approval from the board of directors and the shareholders' meeting, as well as regulatory approval. Currently, the board has no other plans regarding the issuance of RMB shares and has not submitted any applications to regulatory authorities
According to the Zhitong Finance APP, DUALITYBIO-B (09606) announced that on October 17, 2025, the company's board of directors resolved to issue ordinary shares that will be listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board and traded in RMB. The proposed issuance of RMB shares is subject to and limited by (including) market conditions, further approval from the board of directors, approval from shareholders at the company's general meeting, and necessary regulatory approvals.
As of the date of this announcement, apart from the preliminary proposal for the issuance of RMB shares and information disclosed separately in this announcement, the board of directors has no other plans regarding the proposed issuance of RMB shares, nor has it made any applications to the relevant regulatory authorities regarding the proposed issuance of RMB shares
